Sign in
Not yet taking people in United StatesNo phase

Development of Healthcare Transition for Patients With Congenital Adrenal Hyperplasia

Key facts

Who runs it
University of Alabama at Birmingham
Where
Birmingham, United StatesSee the site
Trial code
Status
Not yet recruiting
People taking part
40 people, planned
Starts
Jan 2027
Expected to end
Dec 2029
Type of study
Observational, 3 groups
Treatments tested
  • exposure to healthcare transition protocol
Record updated
14 October 2026

Who can take part

Age
16 years and older
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 12 criteriaShow less

Who can take part

  • YA Participants
  • Diagnosis of congenital adrenal hyperplasia (any subtype or severity)
  • Age ≥16 years
  • Active follow-up within the pediatric endocrinology clinic
  • English-speaking
  • Cognitively able to complete questionnaires with or without assistance
  • Anticipated ability to participate in CAH-T visits during the study period Caregiver Participants
  • Parent, guardian, or primary support person of an enrolled AYA participant Provider Participants
  • Pediatric endocrinologists, nurse practitioners, or transition-related clinical staff involved in CAH care for at least 6 months

Who cannot take part

  • Significant cognitive impairment precluding participation
  • Inability to complete study procedures
  • Inability to provide informed consent/assent

Where in United States

  • University of Alabama at BirminghamBirmingham, United StatesContact: Christy Foster, MDNot yet recruiting

About the trial

What the trial wants to find out

The purpose of this study is to implement and evaluate the feasibility and acceptability of a structured healthcare transition program for adolescents and young adults with congenital adrenal hyperplasia (CAH). The study will also examine preliminary effects of the program on transition readiness, disease-specific self-management knowledge, emergency preparedness, continuity of endocrine care, and health-related quality of life as participants transition from pediatric to adult healthcare services.

The 3 groups in the trial

  • adolescent and young adult with congenital adrenal hyperplasia

    Treatment: exposure to healthcare transition protocol

  • guardian/caregiver of adolescent/young adult with congenital adrenal hyperplasia

    Treatment: exposure to healthcare transition protocol

  • clinical provider of patients with congenital adrenal hyperplasia

    Treatment: exposure to healthcare transition protocol

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Evaluation of a Healthcare Transition Protocol for Patients With Congenital Adrenal Hyperplasia
Record updated
14 October 2026